Nora Volkow

Nora Volkow is a psychiatrist and neuroscientist known for pioneering brain-imaging studies of addiction and serving as director of the National Institute on Drug Abuse. Her work integrated positron emission tomography with clinical psychiatry to map brain circuits involved in substance use disorders, influencing policy, public health, and biomedical research. She has held leadership roles at the National Institutes of Health and collaborated with researchers across academic, governmental, and international institutions.

Early life and education

Volkow was born in Mexico City into a family with ties to science and diplomacy, including relatives who were physicians and diplomats. She completed medical training at the National Autonomous University of Mexico and undertook psychiatric residency at the Universidad Nacional Autónoma de México Faculty of Medicine and subsequent fellowships in the United States at the University of Texas Health Science Center at San Antonio. Early exposure to clinical psychiatry and emerging neuroimaging techniques led her to pursue research training at the Brookhaven National Laboratory, where she worked with teams that included experts from the United States Department of Energy and collaborators affiliated with the National Institutes of Health.

Career

Volkow joined the research staff at Brookhaven National Laboratory, becoming a leader in applying positron emission tomography imaging to study human brain function. She collaborated with investigators from the New York University School of Medicine, Columbia University Irving Medical Center, and the University of Pennsylvania on studies of dopamine and addiction. In 2003 she was appointed director of the National Institute on Drug Abuse within the National Institutes of Health, leading NIDA through initiatives that connected research at institutions such as the Food and Drug Administration, the Substance Abuse and Mental Health Services Administration, and international partners like the World Health Organization. Under her leadership, NIDA expanded programs involving the Drug Enforcement Administration-adjacent policy discussions, cross-agency research consortia with the National Institute on Alcohol Abuse and Alcoholism, and funding partnerships with the Howard Hughes Medical Institute and academic medical centers.

Research and contributions

Volkow's research used positron emission tomography to quantify neurotransmitter systems, particularly the role of dopamine in substance use disorders, reward, and self-control. She published influential studies comparing individuals with opioid, cocaine, methamphetamine, and alcohol use disorders to healthy controls, collaborating with investigators from Harvard Medical School, Yale School of Medicine, Johns Hopkins University, Stanford University School of Medicine, and the University of California, Los Angeles. Her work demonstrated altered dopamine signaling and changes in glucose metabolism in brain regions including the prefrontal cortex, striatum, and amygdala, linking these findings to behaviors studied by researchers at the National Institute of Mental Health and the American Psychiatric Association. She helped map how chronic exposure to substances affects synaptic plasticity and circuits, engaging with basic-science groups at the National Institute on Drug Abuse Intramural Research Program and the National Institute on Aging.

Volkow advocated for translational approaches that connected molecular imaging with treatment development at biotechnology companies, academic translational centers, and consortia supported by the National Cancer Institute and the Bill & Melinda Gates Foundation. She contributed to evidence used in policy forums involving lawmakers from the United States Congress, public health officials from the Centers for Disease Control and Prevention, and criminal-justice stakeholders from state-level departments. Her publications appeared in journals associated with the American Association for the Advancement of Science, the Society for Neuroscience, and the Royal Society of Medicine.

Awards and honors

Volkow's scientific achievements have been recognized by numerous organizations. She received awards and honors from institutions including the National Academy of Medicine, the American College of Neuropsychopharmacology, the Society for Neuroscience, the Royal College of Psychiatrists, and the World Psychiatric Association. She has been a recipient of medals and lectureships conferred by the National Institutes of Health, the Pan American Health Organization, the Johns Hopkins University School of Medicine, and the University of Vienna. Her leadership earned citations from federal entities and honorary degrees from universities such as the Georgetown University, the University of Pennsylvania, and the University of California system.

Personal life

Volkow has balanced a demanding research and administrative career with family life, maintaining ties to medical and academic communities in both Mexico City and the United States. Her network includes collaborations with clinicians and scientists at institutions like the Mayo Clinic, the Cleveland Clinic, the Massachusetts General Hospital, and the Mount Sinai Health System. She has participated in international scientific advisory boards associated with the World Health Organization, the United Nations Office on Drugs and Crime, and academic consortia spanning the University of Cambridge and the Karolinska Institutet.

Category:Mexican neuroscientists Category:Women psychiatrists Category:National Institutes of Health people